Cargando…

Ewing sarcoma fusion oncogene: At the crossroads of transcription and DNA damage response

Detalles Bibliográficos
Autores principales:	Gorthi, Aparna, Bishop, Alexander J. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Author's Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149845/ https://www.ncbi.nlm.nih.gov/pubmed/30250915 http://dx.doi.org/10.1080/23723556.2018.1465014

Ejemplares similares

cGAS-independent STING activation in response to DNA damage
por: Unterholzner, Leonie, et al.
Publicado: (2019)

The perfect PTEN – transcriptional regulation by PTEN dictates sarcoma identity
por: Langdon, Casey G., et al.
Publicado: (2021)

RNA Helicase DDX3 Regulates RAD51 Localization and DNA Damage Repair in Ewing Sarcoma
por: Randolph, Matthew E., et al.
Publicado: (2023)

CX3CL1 at the crossroad of EGF signals: Relevance for the progression of ERBB2(+) breast carcinoma
por: Tardáguila, Manuel, et al.
Publicado: (2013)

Ser(784) phosphorylation: a clinically relevant enhancer of VCP function in the DNA damage response
por: Shao, Jieya
Publicado: (2020)

Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancer
por: Thompson, Timothy C., et al.
Publicado: (2017)

Sarcoma response to targeted therapy dynamically polarizes tumor-associated macrophages
por: Cavnar, Michael J, et al.
Publicado: (2014)

Immunotherapy: Is it different for sarcomas?
por: Cleton-Jansen, Anne-Marie, et al.
Publicado: (2012)

DNA damage tolerance branches out toward sister chromatid cohesion
por: Branzei, Dana
Publicado: (2015)

Inducing DNA damage through R-loops to kill cancer cells
por: Lam, Fred C., et al.
Publicado: (2020)

ERBB2 oncogenicity: ERBIN helps to perform the job
por: Mei, Lin, et al.
Publicado: (2015)

Transcription-dependent DNA double-strand breaks and human disease
por: Cristini, Agnese, et al.
Publicado: (2020)

Chronic activation of DNA damage signals causes tumor immune evasion in the chemoresistant niche
por: Jinushi, Masahisa
Publicado: (2012)

Strong emerging rationale for combining oncogene-targeted agents with immunotherapy
por: Yang, Yan, et al.
Publicado: (2013)

Forging a link between oncogenic signaling and immunosuppression in melanoma
por: Khalili, Jahan S., et al.
Publicado: (2013)

Oncogenic long noncoding RNA FAL1 in human cancer
por: Zhong, Xiaomin, et al.
Publicado: (2015)

A perspective on DNA damage-induced potentiation of the pentose phosphate shunt and reductive stress in chemoresistance
por: Milanese, Chiara, et al.
Publicado: (2020)

MHC-I genotype drives early immune selection of oncogenic mutations
por: Marty, Rachel, et al.
Publicado: (2018)

NKG2D ligands link oncogenic RAS to innate immunity
por: Ho, Samantha S.W., et al.
Publicado: (2013)

Oncogenic β-catenin mutations evade pH-regulated degradation
por: Grillo-Hill, Bree K., et al.
Publicado: (2019)

Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancer
por: Priolo, Carmen, et al.
Publicado: (2015)

Stop relaxing: How DNA damage-induced chromatin compaction may affect epigenetic integrity and disease
por: Oberdoerffer, Philipp
Publicado: (2014)

Reconstruction of Ewing Sarcoma Developmental Context from Mass-Scale Transcriptomics Reveals Characteristics of EWSR1-FLI1 Permissibility
por: Miller, Henry E., et al.
Publicado: (2020)

The PBAF chromatin remodeling complex represses transcription and promotes rapid repair at DNA double-strand breaks
por: Kakarougkas, Andreas, et al.
Publicado: (2015)

Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors
por: Amaddeo, Giuliana, et al.
Publicado: (2012)

Oncogenic regulatory circuits driven by 19q13 rs11672691 underlies prostate cancer aggressiveness
por: Xia, Ji-Han, et al.
Publicado: (2018)

Overexpression of the Fork Protection Complex: a strategy to tolerate oncogene-induced replication stress in cancer cells
por: Pasero, Philippe, et al.
Publicado: (2019)

NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target
por: Lai, Jin-Ping, et al.
Publicado: (2012)

Activity of cytokine-induced killer cells against bone and soft tissue sarcoma
por: Sangiolo, Dario, et al.
Publicado: (2014)

ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer
por: Mishra, Prachi, et al.
Publicado: (2018)

Insulin receptor substrate 4 (IRS4) is a constitutive active oncogenic driver collaborating with HER2 and causing therapeutic resistance
por: Ikink, Gerjon J., et al.
Publicado: (2017)

WNT-mediated gene gating: a novel principle connecting oncogenic super-enhancers with the nuclear pore to drive pathological expression of MYC
por: Göndör, Anita
Publicado: (2020)

Topoisomerase I prevents transcription-replication conflicts at transcription termination sites
por: Liu, Yaqun, et al.
Publicado: (2020)

Fateful music from a talented orchestra with a wicked conductor: Connection between oncogenic BRAF, ER stress, and autophagy in human melanoma
por: Giglio, Paola, et al.
Publicado: (2015)

Sick mitochondria cause telomere damage: implications for disease
por: Kumar, Namrata, et al.
Publicado: (2019)

ESR1 fusions drive endocrine therapy resistance and metastasis in breast cancer
por: Lei, Jonathan T., et al.
Publicado: (2018)

Membrane-anchored chemokine fusion proteins: A novel class of adjuvants for immunotherapy
por: Nelson, Peter J, et al.
Publicado: (2013)

Dicer in action at replication-transcription collisions
por: Ren, Jie, et al.
Publicado: (2015)

Moving nuclear receptor Nur77 to damaged mitochondria for clearance by mitophagy
por: Hu, Mengjie, et al.
Publicado: (2018)

Inhibitors of cell cycle checkpoints and DNA replication cause different responses in normal versus malignant urothelial cells
por: Meuth, Mark
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ve98rfghsppa4i3i03b0qki8dj